Featured in this edition of the Pharmaceutical Engineering® Online Reading Roundup are some articles to start off the new year right! We revisit a favorite topic, sustainability—and will be updating our coverage of this topic with the upcoming March-April 2023 issue of Pharmaceutical Engineering.
Featured in this edition of the Pharmaceutical Engineering® Online Reading Roundup are answers to our most frequently asked questions about publishing in PE. We welcome submissions from members and nonmembers and have a wealth of information available to help guide your journey to becoming a published PE author.
Featured in this edition of iSpeak Reading Roundup, are the top blog posts from January 2022. Discover key insights for cleaning validation practices, risk-based approaches to quality, and more for what the pharmaceutical industry was reading last month.
Featured in this edition of iSpeak Reading Roundup, are the top blog posts from November 2021. Discover key insights for cleaning validation practices, risk-based approaches to quality, and more for what the pharmaceutical industry was reading last month.
Featured in this edition of iSpeak Reading Roundup, are the top blog posts from March 2021. Discover key insights for cleaning validation practices, risk-based approaches to quality, and more for what the pharmaceutical industry was reading last month.
Featured in this edition of iSpeak Reading Roundup, are the top blog posts from February 2021. Discover key insights for cleaning validation practices, risk-based approaches to quality, and more for what the pharmaceutical industry was reading last month.
Featured in this edition of iSpeak Reading Roundup, are the top blog posts from January 2021. Discover key insights for cleaning validation practices, risk-based approaches to quality, and more for what the pharmaceutical industry was reading last month.
Featured in this edition of iSpeak Reading Roundup, are the top blog posts from December 2020. Discover key insights for cleaning validation practices, risk-based approaches to quality, and more for what the pharmaceutical industry was reading last month.
